Cardiovascular Diabetology

Table 3 Determinants of impaired LV function and deformation in OCAD patients

From: The additive effect of metabolic syndrome on left ventricular impairment in patients with obstructive coronary artery disease assessed by 3.0 T cardiac magnetic resonance feature tracking

	GLPS				LVGFI				LVM
	Univariable		Multivariable		Univariable		Multivariable		Univariable		Multivariable
	β	P value	β	P value	β	P value	β	P value	β	P value	β	P value
MetS	− 0.273	0.002	− 0.211	0.002	− 0.198	0.030	− 0.065	0.345	0.268	0.003	0.221	0.003
Male (n)	− 0.183	0.045	− 0.070	0.367	− 0.199	0.029	− 0.174	0.017	0.410	< 0.001	0.336	< 0.001
Age (y)	− 0.029	0.751			− 0.023	0.800			− 0.174	0.057
Smoking	− 0.264	0.003	− 0.215	0.001	− 0.259	0.004	− 0.148	0.043	0.346	< 0.001	0.165	0.047
HbA1c (%)	− 0.294	0.001	− 0.058	0.436	− 0.357	< 0.001	− 0.195	0.004	0.088	0.335
eGFR (mL/min/1.73 m²)	0.117	0.202			0.153	0.094			− 0.043	0.637
NT-proBNP^a (pg/mL)	− 0.629	< 0.001	− 0.556	< 0.001	− 0.670	< 0.001	− 0.609	< 0.001	0.412	< 0.001	0.395	< 0.001
Gensini score	− 0.346	< 0.001	− 0.164	0.016	− 0.291	0.001	− 0.084	0.208	0.183	0.045	0.045	0.553
ACEI/ARB	− 0.311	0.001	− 0.107	0.132	− 0.200	0.028	− 0.032	0.619	0.193	0.034	0.026	0.740

β is the adjusted regression coefficient
Abbreviations as listed in Tables 1 and 2
^aNT-proBNP was log-transformed before being included in the regression analysis

Back to article page

ISSN: 1475-2840

Contact us

Submission enquiries: journalsubmissions@springernature.com